Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recommendations for contouring of gross tumour volume for locally advanced lung cancer using magnetic resonance imaging.

Physics and imaging in radiation oncology·2026

Same author

Steps on the Path to Clinical Translation-A British and Irish Chapter ISMRM Workshop Survey of the UK MRI Community.

Magnetic resonance in medicine·2025

Same author

Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study.

Clinical colorectal cancer·2025

Same author

Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.

Frontiers in oncology·2025

Same author

Deep learning models for deriving optimised measures of fat and muscle mass from MRI.

Scientific reports·2025

Same author

An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study.

The British journal of radiology·2025

Search research articles

Related Experiment Video

Updated: Mar 14, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Cancer heterogeneity and imaging.

James P B O'Connor¹

¹Institute of Cancer Sciences, University of Manchester, Manchester, UK; Department of Radiology, The Christie Hospital NHS Trust, Manchester, UK.

Seminars in Cell & Developmental Biology

|October 9, 2016

Summary

This review explores how medical imaging, including X-ray, CT, MRI, and PET scans, can identify and measure tumor heterogeneity. Understanding this complexity may lead to better cancer biomarkers for guiding treatment decisions.

Keywords:

Biomarker Cancer Heterogeneity Imaging

More Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Related Experiment Videos

Last Updated: Mar 14, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Area of Science:

Oncology
Radiology
Biomarker Discovery

Background:

Tumor heterogeneity is crucial for understanding cancer biology and treatment response.
Genomic, tissue, and imaging scales offer different perspectives on tumor complexity.
Biomarkers derived from tumor heterogeneity can guide therapeutic strategies.

Purpose of the Study:

To review the role and value of imaging methods in identifying, measuring, and mapping tumor heterogeneity.
To highlight the potential of X-ray, CT, MRI, and PET in assessing tumor heterogeneity.
To discuss challenges in validating imaging-based biomarkers for clinical application.

Main Methods:

Review of current literature on medical imaging techniques for tumor heterogeneity.
Focus on X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET).
Analysis of methods for quantifying and mapping heterogeneity across different imaging modalities.

Main Results:

Medical imaging offers valuable tools for characterizing tumor heterogeneity.
Specific imaging techniques show promise in identifying and quantifying intratumoral variations.
Mapping heterogeneity can provide insights into tumor biology and potential treatment responses.

Conclusions:

Imaging-based assessment of tumor heterogeneity holds significant potential for personalized medicine.
Validation and qualification of these imaging biomarkers are essential for clinical integration.
Further research is needed to overcome challenges in translating imaging heterogeneity findings into clinical practice.